---
figid: PMC2739389__nihms124777f2
figlink: /pmc/articles/PMC2739389/figure/F2/
number: F2
caption: Activation of various receptor tyrosine kinases (VEGFR, C-KIT, C-MET, FGFR,
  IGF1R, and others) by their cognate ligands (VEGF, SCF, HGF, FGF, and IGF1/2, respectively)
  leads to proliferation and survival of melanoma cells through two interacting signal
  transduction pathways. Ligand availability through autocrine loops (eg, VEGF), paracrine
  secretion (eg, IGF1), as well as IGFBPs can modulate activation of these pathways.
  Within the MAPK pathway, activated receptors lead to SHC-mediated activation of
  RAS and propagation of signaling through RAF, MEK (also known as MAP2K), and MAPK
  (also known as ERK). Activated MAPK transduces signals that regulate multiple cell
  processes including proliferation, differentiation, angiogenesis, and survival.
  Isolated activation of the MAPK pathway by oncogenic stimuli, such as mutated BRAF,
  results in expression and secretion of IGFBP7, which, in turn, suppresses MAPK activity
  and induces senescence, as seen in benign nevi. Melanomas seem to circumvent this
  negative feedback loop by blocking the expression of IGFBP7 through yet unidentified
  mechanisms. The second essential signaling pathway stimulated by receptor tyrosine
  kinases is the PI3K/AKT pathway. PI3K, a lipid kinase, catalyzes the phosphorylation
  of phosphatidylinositol (PI). Triple phosphorylation of PI is necessary for the
  association of AKT with the cell membrane and its subsequent activation by PDK1.
  The key regulatory component is PTEN, a phosphatase that regulates PI3K and SHC
  phosphorylation. RAS may also regulate PI3K activity. Through activated AKT, a number
  of key mitogenic processes are activated including inhibition of apoptosis, survival
  gene transcription, cell cycle progression, protein translation, and cell growth
  and proliferation. The balance between AKT activation and PTEN regulatory activity
  is a key determinant in cell cycle progression. FGF = fibroblast growth factor;
  HGF = hepatocyte growth factor; IGF = insulinlike growth factor; P = phosphate;
  VEGF = vascular endothelial growth factor; ? = mechanism unknown. For expansion
  of other abbreviations, see Glossary on page 846.
pmcid: PMC2739389
papertitle: 'Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape.'
reftext: Aleksandar Sekulic, et al. Mayo Clin Proc. 2008 Jul;83(7):825-846.
pmc_ranked_result_index: '46322'
pathway_score: 0.9655793
filename: nihms124777f2.jpg
figtitle: 'Malignant Melanoma in the 21st Century: The Emerging Molecular Landscape'
year: '2008'
organisms:
- Homo sapiens
ndex: 6c5f13d6-ded2-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2739389__nihms124777f2.html
  '@type': Dataset
  description: Activation of various receptor tyrosine kinases (VEGFR, C-KIT, C-MET,
    FGFR, IGF1R, and others) by their cognate ligands (VEGF, SCF, HGF, FGF, and IGF1/2,
    respectively) leads to proliferation and survival of melanoma cells through two
    interacting signal transduction pathways. Ligand availability through autocrine
    loops (eg, VEGF), paracrine secretion (eg, IGF1), as well as IGFBPs can modulate
    activation of these pathways. Within the MAPK pathway, activated receptors lead
    to SHC-mediated activation of RAS and propagation of signaling through RAF, MEK
    (also known as MAP2K), and MAPK (also known as ERK). Activated MAPK transduces
    signals that regulate multiple cell processes including proliferation, differentiation,
    angiogenesis, and survival. Isolated activation of the MAPK pathway by oncogenic
    stimuli, such as mutated BRAF, results in expression and secretion of IGFBP7,
    which, in turn, suppresses MAPK activity and induces senescence, as seen in benign
    nevi. Melanomas seem to circumvent this negative feedback loop by blocking the
    expression of IGFBP7 through yet unidentified mechanisms. The second essential
    signaling pathway stimulated by receptor tyrosine kinases is the PI3K/AKT pathway.
    PI3K, a lipid kinase, catalyzes the phosphorylation of phosphatidylinositol (PI).
    Triple phosphorylation of PI is necessary for the association of AKT with the
    cell membrane and its subsequent activation by PDK1. The key regulatory component
    is PTEN, a phosphatase that regulates PI3K and SHC phosphorylation. RAS may also
    regulate PI3K activity. Through activated AKT, a number of key mitogenic processes
    are activated including inhibition of apoptosis, survival gene transcription,
    cell cycle progression, protein translation, and cell growth and proliferation.
    The balance between AKT activation and PTEN regulatory activity is a key determinant
    in cell cycle progression. FGF = fibroblast growth factor; HGF = hepatocyte growth
    factor; IGF = insulinlike growth factor; P = phosphate; VEGF = vascular endothelial
    growth factor; ? = mechanism unknown. For expansion of other abbreviations, see
    Glossary on page 846.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PGF
  - AKT3
  - BRAF
  - HGF
  - FGF9
  - AKT2
  - FGFRL1
  - CCND1
  - CDK4
  - GNAS
  - VEGFB
  - FOXO1
  - CDK6
  - VEGFA
  - FOS
  - PIK3CA
  - GNAL
  - AKT1
  - SHC4
  - SHC2
  - IGF1
  - FGFR4
  - SHC1
  - FGF23
  - SHC3
  - PIK3CB
  - PIK3CD
  - IGF1R
  - IGFBP7
  - KIT
  - KITLG
  - FGFR3
  - FGFR1
  - FGFR2
  - FGF20
  - FGF21
  - IGFBP6
  - FGF8
  - PIK3R4
  - FGF18
  - PIK3CG
  - IGF2
  - FGF10
  - FGF11
  - ELK1
  - FGF13
  - FGF14
  - IGFBP3
  - IGFBP4
  - FGF6
  - FGF7
  - PIK3R6
  - MAPK1
  - FGF17
  - FGF16
  - FGF22
  - FGF12
  - NRAS
  - KRAS
  - FGF4
  - FGF5
  - PDK1
  - PIK3R5
  - MAPK3
  - MET
  - IGFBP1
  - IGFBP2
  - VEGFC
  - MAP2K1
  - MITF
  - MTOR
  - HRAS
  - FGF3
  - PIK3R3
  - PTEN
  - IGFBP5
  - VEGFD
  - MAP2K2
  - FGF19
  - FGF1
  - FGF2
  - Cancer
  - Lung cancer
  - Melanoma
genes:
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF9
  entrez: '2254'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFRL1
  entrez: '53834'
- word: CCND1
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: G1/S
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAS
  entrez: '2778'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: CFOS
  symbol: c-fos
  source: hgnc_alias_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: G1/S
  symbol: Gs
  source: bioentities_symbol
  hgnc_symbol: GNAL
  entrez: '2774'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: IGF1
  symbol: IGF1
  source: hgnc_symbol
  hgnc_symbol: IGF1
  entrez: '3479'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR4
  entrez: '2264'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF23
  entrez: '8074'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: IGF1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP7
  entrez: '3490'
- word: C-KIT
  symbol: C-Kit
  source: hgnc_alias_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: SCF
  symbol: SCF
  source: hgnc_alias_symbol
  hgnc_symbol: KITLG
  entrez: '4254'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR3
  entrez: '2261'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR1
  entrez: '2260'
- word: FGFR
  symbol: FGFR
  source: bioentities_symbol
  hgnc_symbol: FGFR2
  entrez: '2263'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF20
  entrez: '26281'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF21
  entrez: '26291'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP6
  entrez: '3489'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF8
  entrez: '2253'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF18
  entrez: '8817'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IGF2
  symbol: IGF2
  source: hgnc_symbol
  hgnc_symbol: IGF2
  entrez: '3481'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF10
  entrez: '2255'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF11
  entrez: '2256'
- word: ELK1
  symbol: ELK1
  source: hgnc_symbol
  hgnc_symbol: ELK1
  entrez: '2002'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF13
  entrez: '2258'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF14
  entrez: '2259'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP3
  entrez: '3486'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP4
  entrez: '3487'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF6
  entrez: '2251'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF7
  entrez: '2252'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: IGFBP7
  symbol: IGFBP7
  source: hgnc_symbol
  hgnc_symbol: IGFBP7
  entrez: '3490'
- word: MAPK1
  symbol: MAPK1
  source: hgnc_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF17
  entrez: '8822'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF16
  entrez: '8823'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF22
  entrez: '27006'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF12
  entrez: '2257'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: VEGFA
  symbol: VEGFA
  source: hgnc_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF4
  entrez: '2249'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF5
  entrez: '2250'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK3
  symbol: MAPK3
  source: hgnc_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: C-MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP1
  entrez: '3484'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP2
  entrez: '3485'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MITF
  symbol: MITF
  source: hgnc_symbol
  hgnc_symbol: MITF
  entrez: '4286'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF3
  entrez: '2248'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: IGFBP
  symbol: IGFBP
  source: bioentities_symbol
  hgnc_symbol: IGFBP5
  entrez: '3488'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF19
  entrez: '9965'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF1
  entrez: '2246'
- word: FGF
  symbol: FGF
  source: bioentities_symbol
  hgnc_symbol: FGF2
  entrez: '2247'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Melanoma
  source: ''
  identifier: ''
figid_alias: PMC2739389__F2
redirect_from: /figures/PMC2739389__F2
figtype: Figure
---
